The UK pharma industry association has launched legal action against a newly-introduced measure which it says will unfairly delay or deny access to new medicines.
When some parts of the NHS fell victim to the WannaCry ransomware attack in May, it seemed to illustrate fears about the health service: a long-term shortfall in funding and IT infrastructure had l
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
